Semax

Molecular Formula – C149H246N44O42S

Molecular Weight – 3357.9 u

Research Category – Hormone Regulation

Purity – 99.99%

Lab Tested – Yes

Semax is a synthetic heptapeptide analog of ACTH (4-10) that enhances cognitive function and neuroprotection by upregulating BDNF and NGF. It offers a robust platform to study memory, stroke recovery, and neurodegenerative conditions. Researching Semax could lead to advancements in brain health and nootropic therapies.

Semax is a medication which is used in Russia and Eastern Europe for the treatment of a broad range of conditions like brain trauma but predominantly for its claimed nootropic, neuroprotective, and neurorestorative effects.

The mechanism of action of Semax is unknown. It might interact with certain melanocortin receptors or inhibit enkephalinase enzymes. Chemically, Semax is a peptide and a synthetic analogue of a fragment of adrenocorticotropic hormone (ACTH).

Semax was first described by 1991. Although used as a prescription drug in Russia and Eastern Europe, Semax has not been evaluated, approved for use, or marketed in most other countries. The drug is widely sold by online vendors and used as a purported nootropic (cognitive enhancer).